PFE
Pfizer Inc.
Revenue by region
2025, ended Dec 31, 2025
Earlier:
Regions by fiscal year
| USDLine, in USD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 37.1B | 38.7B | 28.1B | 43.3B | 29.7B | 21.5B | 20.3B | 20.1B | 26.0B | 26.4B | 21.7B | 19.1B | 20.3B | 21.3B | 25.3B | 28.9B | 21.5B |
| International Developed Markets | 16.2B | 16.1B | 20.9B | 40.5B | — | — | — | — | — | — | — | — | — | — | — | — | — |
| International Emerging Markets | 9.3B | 8.9B | 10.5B | 17.3B | 20.7B | 8.4B | 8.8B | 8.6B | 11.4B | 10.4B | 11.1B | 11.5B | 11.2B | 10.8B | 10.1B | 10.3B | 7.0B |
| — | — | — | — | 30.8B | 11.8B | 11.8B | 12.1B | 15.1B | 16.0B | 16.0B | 19.0B | 20.1B | 22.5B | 25.6B | 26.0B | 20.7B | |
| Developed Europe | — | — | — | — | 18.3B | 7.8B | 7.7B | 8.0B | 8.5B | 9.3B | 9.7B | 11.7B | 11.7B | 12.5B | 15.2B | 16.2B | 12.6B |
| Developed Rest of World | — | — | — | — | 12.5B | 4.0B | 4.0B | 4.1B | 6.6B | 6.7B | 6.3B | 7.3B | 8.3B | 10.0B | 10.4B | 9.9B | 8.1B |
| Total | 62.6B | 63.6B | 59.6B | 101.2B | 81.3B | 41.7B | 40.9B | 40.8B | 52.5B | 52.8B | 48.9B | 49.6B | 51.6B | 54.7B | 61.0B | 65.2B | 49.3B |